Recent News

By Region: North America

Genetic Mutations Were Key Clue in Anthrax Mailings Case

Abnormal bacteria colonies presented scientists the clue they needed to decipher the genetic “fingerprint” of the anthrax spores used in the 2001 mailings, the Washington Post reported on Saturday (see GSN, March 9). Researchers working at a private facility in Rockville, Md., achieved a scientific breakthrough in decoding the genetic blueprint of the anthrax samples  Read More »

Future in Doubt for International WMD Nonproliferation Center

WASHINGTON — Russia has indicated it intends to withdraw from an international organization established to halt the spread of the nation’s WMD expertise, a move that could force the program’s main hub to close before the end of this year (see GSN, June 19, 2009). The International Science and Technology Center opened in Moscow in  Read More »

CDC Recommends Priorities for Health Agencies

The U.S. Centers for Disease Control and Prevention late last month issued recommendations for how state and local public health officials should direct increasingly tight federal emergency response funds, the Center for Infectious Disease Research and Policy reported on Thursday (see GSN, Dec. 15, 2010). The federal public health agency in past years awarded roughly  Read More »

New Book: Guidelines for Process Safety in Bioprocess … – Business Wire (press release)

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of John Wiley and Sons Ltd’s new book “Guidelines for Process Safety in Bioprocess Manufacturing Facilities” to their offering. This book helps advance process safety in a key area of interest. Currently, no literature exists which is solely dedicated to process safety for the bioprocessing industry. There  Read More »

Duke Human Vaccine Institute signs research agreement to develop pandemic virus vaccines

(Duke University Medical Center) The Duke Human Vaccine Institute today announced a collaboration and strategic agreement with Novartis Vaccines and Diagnostics to enable the rapid development of a vaccine and accelerate preparedness in case of a pandemic virus threat such as pandemic influenza.